The MAP Group completed the acquisition of SKC Beratungsgesellschaft.

The MAP Group, a Cambridge-based specialist pharmaceutical and biotechnology strategic consultancy, completed the acquisition of SKC Beratungsgesellschaft, a Hannover-based consultancy specializing in market access, pricing, and reimbursement. Financial terms were not disclosed. “With the addition of the experienced and talented team from SKC, we advance our objective to ensure patient access to life-changing therapies in Europe and beyond. As the implications of the fast-approaching EU-HTA are at stake, this acquisition is an important step to further expand our pan-European presence and support our clients in an ever-changing landscape, with a global perspective and crucial local expertise," Steve Glass, MAP Group CEO.